16.02.2011
- Sanofi-Aventis SA has agreed in principle to acquire Genzyme Corp for $19.2 billion in cash plus future payments based on the performance of an experimental Genzyme drug, according...
14.02.2011
- Genzyme Corp investors' confidence that the U.S. biotech is close to an agreement to be taken over by Sanofi-Aventis could be shaken if the French drugmaker extends its tender...
10.02.2011
- Sanofi Aventis Chief Executive Chris Viehbacher said in an interview that the French pharmaceuticals group's offer for Genzyme could be extended for a third time, beyond the Feb...
07.02.2011
- The boards of Sanofi-Aventis SA and Genzyme Corp were scheduled to hold separate meetings on Sunday to discuss a potential deal, but talks may linger into the week, sources...
03.02.2011
- French drugmaker Sanofi-Aventis could announce a deal to buy U.S. biotech Genzyme early next week if final negotiations between the companies go smoothly, Le Figaro reported on...
02.02.2011
- France's Sanofi-Aventis has agreed to raise its bid for Genzyme Corp to the low $70s-per-share range, plus a milestone payment based on the performance of an experimental drug, a...
01.02.2011
- U.S. biotech Genzyme and French drugmaker Sanofi-Aventis have reached agreement in principle on the terms of a deal under which Sanofi would acquire Genzyme, three sources familiar...
27.01.2011
- A proxy battle for control of Genzyme is unlikely, given the progress being made in discussions with Sanofi-Aventis, the U.S. biotech group's chief executive said on Thursday...
